Serum Calcium, Albumin and Tumor Stage in Cutaneous Malignant Melanoma

References

• Siegel RL , MillerKD, JemalA. Cancer statistics, 2016. CA Cancer J. Clin.66, 7–30 (2016).
   PubMed Web of Science ®Google Scholar
• American Cancer Society . Cancer Facts & Figures (2016). www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2016/.
   Google Scholar
• Balch CM , BuzaidAC, SoongS-Jet al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin. Surg. Oncol.21(1), 43–52 (2003).
   PubMedGoogle Scholar
• Brochez L , NaeyaertJM. Serological markers for melanoma. Br. J. Dermatol.143(2), 256–268 (2000).
   PubMed Web of Science ®Google Scholar
• Palmer SR , EricksonLA, IchetovkinI, KnauerDJ, MarkovicSN. Circulating serologic and molecular biomarkers in malignant melanoma. Mayo Clin. Proc.86(10), 981–990 (2011).
   PubMed Web of Science ®Google Scholar
• Lumachi F , BrunelloA, RomaA, BassoU. Cancer-induced hypercalcemia. Anticancer Res.29(5), 1551–1555 (2009).
   PubMed Web of Science ®Google Scholar
• Yao M , MurakamiT, ShioiKet al. Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas. Cancer Med.3(4), 845–854 (2014).
   PubMed Web of Science ®Google Scholar
• Thaw SSH , SahmounA, SchwartzGG. Serum calcium, tumor size, and hormone receptor status in women with untreated breast cancer. Cancer Biol. Ther.13(7), 457–461 (2012).
   Web of Science ®Google Scholar
• Kageshita T , MatsuiT, HiraiS, FukudaY, OnoT. Hypercalcaemia in melanoma patients associated with increased levels of parathyroid hormone-related protein. Melanoma Res.9(1), 69–73 (1999).
   PubMed Web of Science ®Google Scholar
• Burt ME , BrennanMF. Hypercalcemia and malignant melanoma. Am. J. Surg.137(6), 790–794 (1979).
   PubMed Web of Science ®Google Scholar
• Kelly MG , WinkleSS, LentzSSet al. Serum calcium and serum albumin are biomarkers that can discriminate malignant from benign pelvic masses. Cancer Epidemiol. Biomarkers Prev.24(10), 1593–1598 (2015).
   PubMed Web of Science ®Google Scholar
• Skinner HG , SchwartzGG. Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol. Biomarkers Prev.17(9), 2302–2305 (2008).
   PubMed Web of Science ®Google Scholar
• Schwartz GG , SkinnerHG. Prospective studies of total and ionized serum calcium in relation to incident and fatal ovarian cancer. Gynecol. Oncol.129(1), 169–172 (2013).
   PubMed Web of Science ®Google Scholar
• Van Dijk JM . Hypercalcemia in prostatic carcinoma: case report and review of the literature. Am. J. Clin. Oncol.16(4), 329–331 (1993).
   PubMed Web of Science ®Google Scholar
• Luparello C . Parathyroid hormone-related protein (PTHrP): a key regulator of life/death decisions by tumor cells with potential clinical applications. Cancers3(1), 396–407 (2011).
   PubMedGoogle Scholar
• Huang DC , YangXF, OchiettiB, FadhilI, CamirandA, KremerR. Parathyroid hormone-related protein: potential therapeutic target for melanoma invasion and metastasis. Endocrinology155(10), 3739–3749 (2014).
   PubMed Web of Science ®Google Scholar
• Danks JA , EbelingPR, HaymanJet al. Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin. J. Bone Miner. Res.4(2), 273–278 (1989).
   PubMed Web of Science ®Google Scholar
• Baird GS . Ionized calcium. Clin. Chim. Acta412(9–10), 696–701 (2011).
   PubMed Web of Science ®Google Scholar
• Caraceni P , DomenicaliM, TovoliAet al. Clinical indications for the albumin use: still a controversial issue. Eur. J. Intern. Med.24(8), 721–728 (2013).
   PubMed Web of Science ®Google Scholar
• Gatta A , VerardoA, BolognesiM. Hypoalbuminemia. Intern. Emerg. Med.7(3), 193–199 (2012).
   PubMedGoogle Scholar
• Matsui T , KageshitaT, IshiharaT, TomiguchiS, TakahashiM, OnoT. Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. Dermatology197(1), 65–68 (1998).
   PubMed Web of Science ®Google Scholar
• Yeung S-CJ , EtonO, BurtonDW, DeftosLJ, Vassilopoulou-SellinR, GagelRF. Hypercalcemia due to parathyroid hormone-related protein secretion by melanoma. Horm. Res.49(6), 288–291 (1998).
   PubMedGoogle Scholar
• Attia P , PhanGQ, DurayPH, RosenbergSA. Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review. Am. J. Clin. Oncol.26(1), 42–45 (2003).
   PubMed Web of Science ®Google Scholar
• Batsis JA , BarryMJ. Metastatic malignant melanoma presenting with hypercalcaemia and bone marrow involvement. J. Eur. Acad. Dermatol. Venereol.20(4), 432–434 (2006).
   PubMed Web of Science ®Google Scholar
• Margarson MP , SoniN. Serum albumin: touchstone or totem?Anaesthesia53(8), 789–803 (1998).
   PubMed Web of Science ®Google Scholar
• Mendez CM , McclainCJ, MarsanoLS. Albumin therapy in clinical practice. Nutr. Clin. Pract.20(3), 314–320 (2005).
   PubMedGoogle Scholar
• Kim J , YooC, LeeD, KimS-W, LeeJ-S, SuhC. Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma. Ann. Hematol.89(4), 391–397 (2010).
   PubMed Web of Science ®Google Scholar
• Don BR , KaysenG. Serum albumin: relationship to inflammation and nutrition. Semin. Dial.17(6), 432–437 (2004).
   PubMed Web of Science ®Google Scholar
• Stehle G , SinnH, WunderAet al. Plasma protein (albumin) catabolism by the tumor itself – implications for tumor metabolism and the genesis of cachexia. Crit. Rev. Oncol. Hematol.26(2), 77–100 (1997).
   PubMed Web of Science ®Google Scholar
• Mundy GR , EdwardsJR. PTH-related peptide (PTHrP) in hypercalcemia. J. Am. Soc. Nephrol.19(4), 672–675 (2008).
   PubMed Web of Science ®Google Scholar
• Grill V , RankinW, MartinTJ. Parathyroid hormone-related protein (PTHrP) and hypercalcaemia. Eur. J. Cancer34(2), 222–229 (1998).
   PubMed Web of Science ®Google Scholar
• El Abdaimi K , PapavasiliouV, GoltzmanD, KremerR. Expression and regulation of parathyroid hormone-related peptide in normal and malignant melanocytes. Am. J. Physiol. Cell Physiol.279(4), C1230–C1238 (2000).
   PubMed Web of Science ®Google Scholar
• Nicholson S , WaxmanJ. Clues from hypercalcaemia. Br. J. Cancer86(7), 1021–1022 (2002).
   PubMed Web of Science ®Google Scholar
• Micozzi MS , AlbanesD, StevensRG. Relation of body size and composition to clinical biochemical and hematologic indices in US men and women. Am. J. Clin. Nutr.50(6), 1276–1281 (1989).
   PubMed Web of Science ®Google Scholar
• Levine D , FisherD. Current status of diagnostic and prognostic markers in melanoma. In: Molecular Diagnostics for Melanoma. ThurinM, MarincolaFM ( Eds). Humana Press, NY, USA, 177–197 (2014).
   Google Scholar
• Sorva A , ElfvingS, PohjaP, TilvisRS. Assessment of calcaemic status in geriatric hospital patients: serum ionized calcium versus albumin-adjusted total calcium. Scand. J. Clin. Lab. Invest.48(6), 489–494 (1988).
   PubMed Web of Science ®Google Scholar
• Björkman MP , SorvaAJ, TilvisRS. Calculated serum calcium is an insufficient surrogate for measured ionized calcium. Arch. Gerontol. Geriatr.49(3), 348–350 (2009).
   PubMed Web of Science ®Google Scholar